[
    [
        {
            "time": "2018-02-28",
            "original_text": "医药生物行业周报：业绩兑现期 围绕一致性评价及业绩超预期精选标的",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩兑现",
                    "一致性评价",
                    "精选标的"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业周报：业绩兑现期 围绕一致性评价及业绩超预期精选标的",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-02-28",
            "original_text": "[强烈推荐评级]健帆生物(300529)：血液灌流器渗透率持续提升 实现业绩41%高增长 超市场预期",
            "features": {
                "keywords": [
                    "健帆生物",
                    "血液灌流器",
                    "渗透率",
                    "业绩增长",
                    "市场预期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强烈推荐评级]健帆生物(300529)：血液灌流器渗透率持续提升 实现业绩41%高增长 超市场预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-02-28",
            "original_text": "早安！方正最新观点20180228",
            "features": {
                "keywords": [],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "早安！方正最新观点20180228",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-02-28",
            "original_text": "【医药丨周小刚】健帆生物(300529)：降价不改增长预期，公司步入快速增长通道",
            "features": {
                "keywords": [
                    "健帆生物",
                    "降价",
                    "增长预期",
                    "快速增长通道"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药丨周小刚】健帆生物(300529)：降价不改增长预期，公司步入快速增长通道",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]